Pfizer Says Vaccine Safely Produces Antibodies in Younger Kids

Sep.20 -- Johns Hopkins University Bloomberg School of Public Health Professor of Epidemiology Amber D’Souza discusses Covid-19 vaccines for kids as Pfizer Inc and BioNTech Inc. release data on a large-scale trial in children ages 5 to 11. The Bloomberg School of Public Health is supported by Michael R. Bloomberg, founder and majority owner of Bloomberg LP, the parent company of Bloomberg News.

Comments / 0

Published by

Bloomberg from Video Elephant


Comments / 0